Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors-Reference-Cited by-同舟云学术

Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors

Published:1996-01 Issue:1 Volume:116 Page:105-114
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

de Winter Johan P.,ten Dijke Peter,de Vries Carlie J.M.,van Achterberg Tanja A.E.,Sugino Hiromu,de Waele Peter,Huylebroeck Danny,Verschueren Kristin,van den Eijnden-van Raaij Adriana J.M.

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference44 articles.

1. Follistatin inhibits the mesoderm-inducing activity of activin A and the vegetalizing factor from chicken embryo

2. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors

3. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors

4. Characterization of activin A binding sites on the human leukemia cell line K562

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spemann-Mangold organizer and mesoderm induction;Cells & Development;2024-06

2. FSTL1: A double-edged sword in cancer development;Gene;2024-05

3. Follistatin and follistatin-like 3 in metabolic disorders;Prostaglandins & Other Lipid Mediators;2023-12

4. Gastrointestinal pharmacology activins in liver health and disease;Biochemical Pharmacology;2023-08

5. Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers;Frontiers in Cell and Developmental Biology;2022-10-17